title: In vivo administration of interleukin 1 elicits increased Ia antigen expression on B cells through the induction of interleukin 4.
abstract: The effects of the in vivo administration of interleukin 1 (IL 1) on lymphocytes from lymph node and spleen were analyzed. Mice received five daily subcutaneous (s.c.) injections of various doses of human recombinant IL 1 beta. Either 1 or 7 days after IL 1 treatment, spleens, popliteal and inguinal lymph nodes were collected. Lymphadenosis and splenomegaly were observed in the IL 1-treated animals. Lymph nodes from IL 1-treated mice contained a higher percentage of B cells than controls, and B cells from IL 1-treated mice expressed dramatically increased levels of Ia antigen. Lymphadenosis and splenomegaly, as well as the changes in subset distributions and Ia expression were transient. Concomitant treatment of mice with IL 1 and anti-IL 4 monoclonal antibody suppressed IL 1 effects on B cell Ia expression, but not on the B/T cell ratio. In situ hybridization analyses revealed that IL 1 treatment induced the expression of mRNA for IL 4, interferon-gamma, and IL 2 in lymph node and spleen cells. The distribution of cells expressing the various cytokine mRNA was markedly different between the spleens and lymph nodes.
authors.affiliation: Hypersensitivity Diseases Research Unit, Upjohn Company, Kalamazoo.
authors.forename: L M
authors.initials: LM
authors.lastname: Killar
authors.forename: C A
authors.initials: CA
authors.lastname: Hatfield
authors.forename: S R
authors.initials: SR
authors.lastname: Carding
authors.forename: M
authors.initials: M
authors.lastname: Pan
authors.forename: G E
authors.initials: GE
authors.lastname: Winterrowd
authors.forename: K
authors.initials: K
authors.lastname: Bottomly
mesh_terms: D000818:Animals; D000943:Antigens, Differentiation / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D005786:Gene Expression Regulation; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D007158:Immunologic Techniques; D007371:Interferon-gamma / Q000235:genetics; D007375:Interleukin-1 / Q000494:pharmacology*; D007376:Interleukin-2 / Q000235:genetics; D015847:Interleukin-4 / Q000235:genetics / Q000502:physiology*; D008199:Lymphadenitis / Q000139:chemically induced; D051379:Mice; D008811:Mice, Inbred DBA; D012333:RNA, Messenger / Q000235:genetics; D013163:Splenomegaly / Q000139:chemically induced; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*
chemical_list: D000943:Antigens, Differentiation; D000949:Histocompatibility Antigens Class II; D007375:Interleukin-1; D007376:Interleukin-2; D012333:RNA, Messenger; D015847:Interleukin-4; D007371:Interferon-gamma